Six Australian health technology and biotech startups have shared $13.5 million in funding through the second round of the federal government-backed CUREator+ commercialisation program.
The funding includes almost $6 million for three companies developing AI-enabled cardiovascular technology, digital biomarkers and a platform for assessing vertigo and dizziness.
...